Statins and Prostate Cancer Recurrence: RCT Now Needed, Say Experts

It's time for a randomized trial to evaluate the effect of statins on outcomes in men with prostate cancer undergoing treatment, say experts in the field.

The calls for a prospective trial have been prompted by retrospective observational trials that have shown a significant reduction in the risk for biochemical recurrence in men treated for the disease who were also taking statins. Two such studies have been published recently.